Journal of Leukocyte Biology BioLegend: Treg, Th17, Stem Cell
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0507268 on September 19, 2007

Published online before print September 19, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0507268v1
82/6/1407    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waggoner, S. N.
Right arrow Articles by Hahn, Y. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waggoner, S. N.
Right arrow Articles by Hahn, Y. S.
(Journal of Leukocyte Biology. 2007;82:1407-1419.)
© 2007 by Society for Leukocyte Biology

HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production

Stephen N. Waggoner*,1, Caroline H. T. Hall* and Young S. Hahn*,{dagger},2

* Departments of Microbiology, Beirne Carter Center for Immunology Research, and
{dagger} Pathology, University of Virginia, Charlottesville, Virginia, USA

2Correspondence: Department of Microbiology and Beirne B. Carter Center for Immunology Research, University of Virginia, HSC, Box 801386, Charlottesville, VA 22903, USA. E-mail: ysh5e{at}virginia.edu

ABSTRACT

Dendritic cells (DCs) isolated from patients with chronic hepatitis C virus (HCV) infection display an impaired capacity to generate type 1 CD4+ T cell immunity. Several reports have described an immunomodulatory function for the HCV core protein, and circulating core has been shown to associate with the putative gC1q receptor, gC1qR, expressed on host immune cells. However, the molecular mechanism(s) of HCV core-mediated DC dysfunction has not been defined. Herein, ligation of gC1qR on human monocyte-derived DCs (MDDCs) with HCV core or anti-gC1qR agonist antibody was shown to inhibit TLR-induced IL-12 production but not the production of other TLR-stimulated cytokines. Furthermore, engagement of gC1qR on MDDCs resulted in reduced IFN-{gamma} secretion by allogeneic CD4+ T lymphocytes during mixed lymphocyte culture. Differentiation of CD4+ T cells cocultured with HCV core- or anti-gC1qR antibody-treated MDDCs was also skewed toward production of Th2 cytokines, including IL-4. Importantly, that addition of IL-12 rescued IFN-{gamma} production and Th1 differentiation by CD4+ T cells. Therefore, engagement of gC1qR on DCs by HCV core limits the induction of Th1 responses and may contribute to viral persistence.

Key Words: human • DC • Th2 cells • viral • inflammation




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
A. Dolganiuc and G. Szabo
T cells with regulatory activity in hepatitis C virus infection: what we know and what we don't
J. Leukoc. Biol., September 1, 2008; 84(3): 614 - 622.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society for Leukocyte Biology.